Cel-Sci Corp (CVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-1993 | 06-1993 | 03-1993 | 12-1992 | 09-1992 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,156 | 2,351 | 1,617 | 1,084 | 3,190 |
| Marketable Securities | 8,366 | 9,044 | 9,997 | 11,224 | 10,032 |
| Receivables | 455 | 294 | 374 | 673 | 186 |
| Other current assets | 63 | 227 | 514 | 20 | 40 |
| TOTAL | $11,040 | $11,916 | $12,502 | $13,001 | $13,448 |
| Non-Current Assets | |||||
| PPE Net | 541 | 340 | 256 | 257 | 223 |
| Other Non-Current Assets | 297 | 305 | 306 | 313 | 316 |
| TOTAL | $838 | $645 | $562 | $570 | $539 |
| Total Assets | $11,633 | $12,332 | $12,841 | $13,350 | $13,770 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 231 | 202 | 141 | 133 | 109 |
| Accrued Expenses | 223 | 126 | 126 | 200 | 200 |
| Other current liabilities | 52 | 31 | 22 | 104 | 96 |
| TOTAL | $506 | $359 | $288 | $437 | $405 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 183 | 132 | 108 | 0 | 62 |
| TOTAL | $183 | $132 | $108 | $N/A | $62 |
| Total Liabilities | $688 | $490 | $396 | $437 | $467 |
| Shareholders' Equity | |||||
| Common Shares | 42 | 42 | 42 | 42 | 42 |
| Retained earnings | -15,705 | -14,788 | -14,185 | -13,708 | -13,300 |
| Other shareholders' equity | 0 | 0 | 0 | -1 | -1 |
| TOTAL | $10,945 | $11,842 | $12,445 | $12,913 | $13,302 |
| Total Liabilities And Equity | $11,633 | $12,332 | $12,841 | $13,350 | $13,769 |